Photodynamic Therapy with Verteporfin for Corneal Neovascularization

GALANTUOMO, MARIA SILVANA;PEIRETTI, ENRICO;ZUCCA, IGNAZIO ALBERTO;FOSSARELLO, MAURIZIO
2006-01-01

Abstract

Purpose: To describe the effect of photodynamic therapy (PDT) using verteporfin (Visudyne ®) on corneal neovascularization (CNV) in twenty patients. Methods: Twenty patients with corneal neovascularization were treated with a non-thermal laser light at 689 nm delivered fifteen minutes after an intravenous infusion of verteporfin. Postoperative outcome of neovascularization was followed clinically (inflammation, intraocular pressure and visual acuity) and photographically (colour photographs and corneal fluorescein and indocyanine green (ICG) angiography) for a minimum of one year. Results: Successful photothrombosis of corneal neovasculararization was obtained immediately after treatment in all patients, and regression was verified by corneal fluorescein and ICG angiography. In 12 patients partial vessel recanalization was observed after one month, and treatment was repeated, with complete regression of new vessel. No relevant side effects were observed in our cases. Conclusions: PDT with verteporfin is an effective and safe procedure indicated for patients with corneal neovascularization: howerver, multiple sessions may be required.
2006
Inglese
2006 ARVO Annual Meeting
0146-0404
Paul L. Kaufman, MD
ROCKVILLE
47
1629
1552
5783
4232
ARVO 2006 ANNUAL MEETING
maggio 2006
FORT LAUDERDALE, FLORIDA
internazionale
photodynamic therapy
4 Contributo in Atti di Convegno (Proceeding)::4.1 Contributo in Atti di convegno
Galantuomo, MARIA SILVANA; Peiretti, Enrico; Zucca, IGNAZIO ALBERTO; Fossarello, Maurizio
273
4
4.1 Contributo in Atti di convegno
none
info:eu-repo/semantics/conferencePaper
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie